InvestSMART

Cynata Therapeutics Limited (ASX: CYP) - Announcements

- Current share price for CYP : $0.011

ASX company news and announcements for Cynata Therapeutics Limited (CYP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cynata Therapeutics Limited (CYP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cynata Therapeutics Limited (CYP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cynata Therapeutics Limited (CYP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 Appendix 3Y - Dr Kilian Kelly 23 Nov 2023 9:13AM $0.125 $0.011 fallen by 91.20%
$3 Appendix 3Ys x 5 20 Nov 2023 4:41PM $0.120 $0.011 fallen by 90.83%
$3 Notification regarding unquoted securities - CYP 20 Nov 2023 4:31PM $0.120 $0.011 fallen by 90.83%
$3 Notification of cessation of securities - CYP 14 Nov 2023 4:29PM $0.130 $0.011 fallen by 91.54%
$3 Cynata Receives $2.315m R&D Tax Incentive Refund 14 Nov 2023 8:55AM $0.130 $0.011 fallen by 91.54%
$3 Final Director's Interest Notice 13 Nov 2023 2:45PM $0.130 $0.011 fallen by 91.54%
$3 Results of AGM 13 Nov 2023 12:40PM $0.130 $0.011 fallen by 91.54%
$3 AGM Presentations 13 Nov 2023 8:32AM $0.135 $0.011 fallen by 91.85%
$3 Phase 3 SCUlpTOR Osteoarthritis Clinical Trial Progress 6 Nov 2023 9:14AM $0.135 $0.011 fallen by 91.85%
$3 First USA site initiated in aGvHD trial 2 Nov 2023 9:30AM $0.125 $0.011 fallen by 91.20%
$3 Quarterly Activity Report & Appendix 4C 26 Oct 2023 2:18PM $0.120 $0.011 fallen by 90.83%
$3 Annual Report to Shareholders 12 Oct 2023 2:43PM $0.130 $0.011 fallen by 91.54%
$3 Letter to Shareholders, Notice of AGM & Proxy Form 12 Oct 2023 2:41PM $0.130 $0.011 fallen by 91.54%
$3 Dr David Atkins not to stand for re-election at AGM 9 Oct 2023 8:57AM $0.130 $0.011 fallen by 91.54%
$3 Investor Webinar Presentation 18 Sep 2023 4:33PM $0.135 $0.011 fallen by 91.85%
$3 Date of AGM and Closing Date for Director Nominations 18 Sep 2023 9:41AM $0.135 $0.011 fallen by 91.85%
$3 Appendix 4G 28 Aug 2023 5:57PM $0.135 $0.011 fallen by 91.85%
$3 Corporate Governance Statement 28 Aug 2023 5:57PM $0.135 $0.011 fallen by 91.85%
$3 Appendix 4E & Annual Report 28 Aug 2023 5:57PM $0.135 $0.011 fallen by 91.85%
$3 Approval of Clinical Trial of CYP-001 in Kidney Transplant 21 Aug 2023 9:13AM $0.140 $0.011 fallen by 92.14%
$3 Phase 2 Trial of CYP-001 in aGvHD Open for Recruitment 10 Aug 2023 9:03AM $0.145 $0.011 fallen by 92.41%
$3 Investor Webinar Presentation 27 Jul 2023 8:21AM $0.145 $0.011 fallen by 92.41%
$3 Quarterly Activity Report & Appendix 4C 26 Jul 2023 9:03AM $0.145 $0.011 fallen by 92.41%
$3 Ceasing to be a substantial holder 25 Jul 2023 5:04PM $0.145 $0.011 fallen by 92.41%
$3 Strategic Review of Cynata Clinical Development Portfolio 24 Jul 2023 9:39AM $0.135 $0.011 fallen by 91.85%

151 - 175 of 702 results

Page 7 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.